Profound Medical Analyst Ratings
Profound Medical Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/04/2022 | — | Raymond James | Upgrades | Outperform → Strong Buy | |
| 03/07/2022 | 207.69% | Cowen & Co. | $28 → $14 | Maintains | Outperform |
| 02/22/2022 | 405.49% | Raymond James | $28 → $23 | Downgrades | Strong Buy → Outperform |
| 09/15/2020 | — | Jefferies | Initiates Coverage On | → Buy | |
| 09/10/2020 | 383.52% | Lake Street | → $22 | Initiates Coverage On | → Buy |
| 04/01/2020 | 229.67% | Cowen & Co. | → $15 | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 2022 年 4 月 11 日 | — | 雷蒙德·詹姆 | 升級 | 跑贏大盤 → 強勢買入 | |
| 03/07/2022 | 207.69% | Cowen & Co. | 28 美元 → 14 美元 | 維護 | 跑贏大盤 |
| 02/22/2022 | 405.49% | 雷蒙德·詹姆 | 28 美元 → 23 美元 | 降級 | 強勢買入 → 跑贏大盤 |
| 2020 年 9 月 15 日 | — | 傑富瑞集團 | 啓動覆蓋範圍開啓 | → 購買 | |
| 2020 年 10 月 9 日 | 383.52% | 湖街 | → 22 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 2020 年 1 月 4 日 | 229.67% | Cowen & Co. | → 15 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
Profound Medical Questions & Answers
深刻的醫學問題與解答
The latest price target for Profound Medical (NASDAQ: PROF) was reported by Raymond James on November 4, 2022. The analyst firm set a price target for $0.00 expecting PROF to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
雷蒙德·詹姆斯於2022年11月4日公佈了Profound Medical（納斯達克股票代碼：PROF）的最新目標股價。該分析公司將目標股價定爲0.00美元，預計PROF將在12個月內降至12個月內（可能下跌-100.00％）。去年有3家分析公司公佈了評級。
The latest analyst rating for Profound Medical (NASDAQ: PROF) was provided by Raymond James, and Profound Medical upgraded their strong buy rating.
雷蒙德·詹姆斯對Profound Medical（納斯達克股票代碼：PROF）的最新分析師評級由雷蒙德·詹姆斯提供，而Profound Medical則上調了
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Profound Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Profound Medical was filed on November 4, 2022 so you should expect the next rating to be made available sometime around November 4, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Profound Medical的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Profound Medical的最新評級是在2022年11月4日發佈的，因此您應該預計下一個評級將在2023年11月4日左右公佈。
While ratings are subjective and will change, the latest Profound Medical (PROF) rating was a upgraded with a price target of $0.00 to $0.00. The current price Profound Medical (PROF) is trading at is $4.55, which is out of the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的Profound Medical（PROF）評級已上調，目標股價爲0.00美元至0.00美元。Profound Medical（PROF）目前的交易價格爲4.55美元，超出了分析師的預期區間。
譯文內容由第三人軟體翻譯。